Product Information

DOXAZOSIN MESYLATE 8 MG TAB is a generic product labeled by Zydus Pharmaceuticals (USA) Inc., priced at $0.0995 per EA under NDC 68382078610. Its NADAC has been published 413 times since Dec 26, 2018.

FDA first approved this application on Jul 7, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

DOXAZOSIN MESYLATE 8 MG TAB

Doxazosin
$0.0995per EA

Strength

8 mg/1

NDC

68382078610

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

DOXAZOSIN MESYLATE

Approval Type

Generic (ANDA)

FDA Application

ANDA208719

FDA Approved

7/7/2017

TE Code

AB

On Market Since

8/31/2017

Pharmacological Classes

Adrenergic alpha-Antagonists
alpha-Adrenergic Blocker

Price Statistics

The NADAC for DOXAZOSIN MESYLATE 8 MG TAB has been published 413 times since Dec 26, 2018, and over the history we have for it it has declined 59.5%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0995 per EA
All-time high$0.2459 (Jan 16, 2019)
All-time low$0.0731 (Nov 20, 2024)
52-week high$0.1097
52-week low$0.0944
Median price$0.1168
Average price$0.1332
Largest weekly change-36.8% (Jan 20, 2021)
Weeks tracked413
Tracking sinceDec 26, 2018

Price History

1W

+5.5%

1M

+2.0%

3M

-0.6%

6M

-6.2%

1Y

-8.7%

3Y

-14.8%

5Y

-10.0%

All

-59.5%

Generic Alternatives

The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of DOXAZOSIN MESYLATE 8 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for DOXAZOSIN MESYLATE 8 MG TAB, manufactured by Zydus Pharmaceuticals (USA) Inc., is $0.0995 per EA (NDC 68382078610), effective Nov 18, 2026.

How has the price of DOXAZOSIN MESYLATE 8 MG TAB changed over time?

Over the history we have for it, the NADAC for DOXAZOSIN MESYLATE 8 MG TAB has declined 59.5%. It has been tracked across 413 weekly CMS publications since Dec 26, 2018.

What are the highest and lowest recorded NADAC prices for DOXAZOSIN MESYLATE 8 MG TAB?

Since Dec 26, 2018, the NADAC for DOXAZOSIN MESYLATE 8 MG TAB has ranged from a low of $0.0731 (Nov 20, 2024) to a high of $0.2459 (Jan 16, 2019), with a median of $0.1168 per EA.

Are there cheaper alternatives to DOXAZOSIN MESYLATE 8 MG TAB?

6 manufacturers publish a NADAC-priced product with the same active ingredient and strength as DOXAZOSIN MESYLATE 8 MG TAB in a comparable dosage form, but none are currently priced below it.

Who manufactures DOXAZOSIN MESYLATE 8 MG TAB?

DOXAZOSIN MESYLATE 8 MG TAB (NDC 68382078610) is labeled by Zydus Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.